Sumi Mukhopadhyay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sumi Mukhopadhyay has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Bibhuti Saha
Department of Tropical Medicine, Calcutta School of Tropical Medicine, Kolkata, India
16 shared publicationsGoutam Patra
Department of Laboratory Medicine, Kolkata, India
6 shared publicationsManab Ghosh
Department of Tropical Medicine Kolkata West Bengal India
6 shared publications- Souvik Datta
Department of Biochemistry and Molecular Biology, College of Medicine University of Nebraska Medical Center Omaha NE USA
4 shared publications Sudeshna Mallik
Department of Tropical Medicine, School of Tropical Medicine, Kolkata, West Bengal, India
4 shared publicationsDolanchampa Modak
Department of Tropical Medicine, Calcutta School of Tropical Medicine, Government of West Bengal, Kolkata, West Bengal, India
3 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 13 (3) , 1603-1611
COVID-19 vaccine-elicited immune mediators and their contribution to protective immunity
SARS-CoV-2, a highly transmissible virus triggered the COVID-19 pandemic inflicting devastating impact on public health and global economy; thus, the development of a vaccine was deemed the most efficient strategy. The immune system is a network of specialized cell types that interacts with cytokines to orchestrate protective responses. Until recently, investigators only evaluated vaccine efficacy with an emphasis on secreted antibodies, despite advancements in vaccinology no well-confirmed immunological correlates of vaccine-induced protection have been recognized. Technological and conceptual advances in cell-mediated immunology have resulted in numerous novel immunological signals, which could function as classifiers for vaccine-induced protection. Cytokine responses are essential for triggering and retaining humoral responses, which could potentially impact vaccination efficiency, thus, profiling might uncover vital information on the indicators of vaccine response and long-term protective variables. This integrated immunological approach to vaccine response provides a broader perspective and ensures an improved comprehension of the pathways and mechanisms involved. Here we aim to summarize the mechanism of action of the different vaccines developed and examine several immunological mediators associated with SARS-CoV2 immunization. We also provide insights, on new possibilities correlating with vaccine-induced immune responses and their effectiveness in defining protective immunity.
- 27 February 2026
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 13 (3) , 1603-1611
Open AccessCOVID-19 vaccine-elicited immune mediators and their contribution to protective immunity
SARS-CoV-2, a highly transmissible virus triggered the COVID-19 pandemic inflicting devastating impact on public health and global economy; thus, the development of a vaccine was deemed the most efficient strategy. The immune system is a network of specialized cell types that interacts with cytokines to orchestrate protective responses. Until recently, investigators only evaluated vaccine efficacy with an emphasis on secreted antibodies, despite advancements in vaccinology no well-confirmed immunological correlates of vaccine-induced protection have been recognized. Technological and conceptual advances in cell-mediated immunology have resulted in numerous novel immunological signals, which could function as classifiers for vaccine-induced protection. Cytokine responses are essential for triggering and retaining humoral responses, which could potentially impact vaccination efficiency, thus, profiling might uncover vital information on the indicators of vaccine response and long-term protective variables. This integrated immunological approach to vaccine response provides a broader perspective and ensures an improved comprehension of the pathways and mechanisms involved. Here we aim to summarize the mechanism of action of the different vaccines developed and examine several immunological mediators associated with SARS-CoV2 immunization. We also provide insights, on new possibilities correlating with vaccine-induced immune responses and their effectiveness in defining protective immunity.
- Open Access
- 23 September 2025
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 27, 1-44
Interplay between innate immune cells and inflammatory mediators in dengue infection: an evolving therapeutic paradigm
Background: Dengue is one of the neglected tropical diseases endemic to tropical and subtropical regions worldwide. Due to its substantial disease burden, this arthropod-borne viral disease is a significant public health concern. Infection involving any one of the five distinct serotypes causes a wide range of disease manifestations, from self-limiting to mild to life-threatening outcomes. Methods: The current review comprehensively provides an overview of dengue virus-mediated immunopathogenesis with special emphasis on innate immune cells, their pathogen recognition sensors and their association with pathogenesis. Additionally we have also briefly discussed recent advancements in vaccine studies and the development of therapeutics over the last decade. Results: The immunological response to dengue virus involves an amalgamation of a variety of innate cells and inflammatory mediators, resulting in the favouring or dampening of the antiviral response. Viral components activating innate cells through pattern recognition receptors, such as Toll-like receptors, retinoic-acid-inducible gene I and melanoma differentiation-associated gene 5, are vital in eliciting a downstream signalling cascade, which culminates in the secretion of inflammatory proteins. Conclusion: Understanding the specific mechanisms involved in the acute phase of infection is indispensable for detecting differential biomarkers against flavivirus infections as well as designing more efficient therapeutic agents and vaccines.
- 23 September 2025
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 27, 1-44
Open AccessInterplay between innate immune cells and inflammatory mediators in dengue infection: an evolving therapeutic paradigm
Background: Dengue is one of the neglected tropical diseases endemic to tropical and subtropical regions worldwide. Due to its substantial disease burden, this arthropod-borne viral disease is a significant public health concern. Infection involving any one of the five distinct serotypes causes a wide range of disease manifestations, from self-limiting to mild to life-threatening outcomes. Methods: The current review comprehensively provides an overview of dengue virus-mediated immunopathogenesis with special emphasis on innate immune cells, their pathogen recognition sensors and their association with pathogenesis. Additionally we have also briefly discussed recent advancements in vaccine studies and the development of therapeutics over the last decade. Results: The immunological response to dengue virus involves an amalgamation of a variety of innate cells and inflammatory mediators, resulting in the favouring or dampening of the antiviral response. Viral components activating innate cells through pattern recognition receptors, such as Toll-like receptors, retinoic-acid-inducible gene I and melanoma differentiation-associated gene 5, are vital in eliciting a downstream signalling cascade, which culminates in the secretion of inflammatory proteins. Conclusion: Understanding the specific mechanisms involved in the acute phase of infection is indispensable for detecting differential biomarkers against flavivirus infections as well as designing more efficient therapeutic agents and vaccines.
- Open Access
- 13 June 2025
- Published by Wolters Kluwer Health in Annals of Medical Science & Research
- Vol. 4 (Suppl 1) , S87-S92
Unraveling novel biomarkers in Indian post-kala-azar dermal leishmaniasis using proteomics
Recent years have seen a rise in the use of mass spectrometry (MS)-based methods in proteome profiling research. MS-based proteomics has been increasingly implemented in various disciplines to identify and quantify biomolecules in a variety of biological specimens. MS-based proteomics is increasingly being applied for biomarker discovery due to its high sensitivity and specificity making it superior to any other available technology. Post-kala-azar dermal leishmaniasis diagnosis is challenging due to the low parasite burden and its symptomatic resemblance with other diseases like vitiligo or leprosy. Therefore, it is imperative to identify promising biomarkers with translational utility. The development of point-of-care assays using these biomarkers holds considerable potential for successful case diagnosis and for the efficient implementation of the ongoing Kala Azar Elimination Program.
- 13 June 2025
- Published by Wolters Kluwer Health in Annals of Medical Science & Research
- Vol. 4 (Suppl 1) , S87-S92
Open AccessUnraveling novel biomarkers in Indian post-kala-azar dermal leishmaniasis using proteomics
Recent years have seen a rise in the use of mass spectrometry (MS)-based methods in proteome profiling research. MS-based proteomics has been increasingly implemented in various disciplines to identify and quantify biomolecules in a variety of biological specimens. MS-based proteomics is increasingly being applied for biomarker discovery due to its high sensitivity and specificity making it superior to any other available technology. Post-kala-azar dermal leishmaniasis diagnosis is challenging due to the low parasite burden and its symptomatic resemblance with other diseases like vitiligo or leprosy. Therefore, it is imperative to identify promising biomarkers with translational utility. The development of point-of-care assays using these biomarkers holds considerable potential for successful case diagnosis and for the efficient implementation of the ongoing Kala Azar Elimination Program.
- 4 June 2024
- Published by Springer Nature in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
- Vol. 94 (3) , 671-676
Decreased Thrombospondin-1 Titers Are Hallmarks of Patients with Severe Dengue Infection
- 4 June 2024
- Published by Springer Nature in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
- Vol. 94 (3) , 671-676
Decreased Thrombospondin-1 Titers Are Hallmarks of Patients with Severe Dengue Infection
- 4 October 2023
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 44 (5-6) , 418-435
Development of a novel lectin-based gold nanoparticle point-of-care immunoassay for rapid diagnosis of patients with severe Dengue infection
Rapid diagnosis of patients with severe Dengue infection can be useful for the efficient clinical management of cases caused by the Dengue virus. Lateral Flow Immunoassay (LFIA) have been broadly used for rapid Dengue diagnosis, because of their quick readouts with the human eye, simplicity of use, and affordability. Despite the availability of several commercial Dengue point-of-care assays, none has shown to be successful in discriminating between severe and nonsevere forms of Dengue infection. In the current study, for the first time, a novel lectin-based point-of-care assay for the early detection of patients with severe Dengue infection with gold-adorned sheets as detection labels is being reported. In this assay, Dengue severity was diagnosed by detecting the glycosylation profile of vitronectin, a known Dengue severity marker. Two lectins were employed namely DSA (Datura stramonium) and MAA (Maackia amurensis) that can recognize specific glycans like galactose Gal-(1-4) GlcNAc and sialic acid in an (α2-3) linkage, which displayed high sensitivity and high specificity, i.e. 90% and 85% for DSA and 90.91% and 95% for MAA. The new assay has a detection limit of 5 µg µl-1 and enables the quick (30 min) and sensitive detection of severe Dengue cases. The reported point-of-care immunoassay exhibits considerable promise for early identification of patients with Dengue severity.
- 4 October 2023
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 44 (5-6) , 418-435
Development of a novel lectin-based gold nanoparticle point-of-care immunoassay for rapid diagnosis of patients with severe Dengue infection
Rapid diagnosis of patients with severe Dengue infection can be useful for the efficient clinical management of cases caused by the Dengue virus. Lateral Flow Immunoassay (LFIA) have been broadly used for rapid Dengue diagnosis, because of their quick readouts with the human eye, simplicity of use, and affordability. Despite the availability of several commercial Dengue point-of-care assays, none has shown to be successful in discriminating between severe and nonsevere forms of Dengue infection. In the current study, for the first time, a novel lectin-based point-of-care assay for the early detection of patients with severe Dengue infection with gold-adorned sheets as detection labels is being reported. In this assay, Dengue severity was diagnosed by detecting the glycosylation profile of vitronectin, a known Dengue severity marker. Two lectins were employed namely DSA (Datura stramonium) and MAA (Maackia amurensis) that can recognize specific glycans like galactose Gal-(1-4) GlcNAc and sialic acid in an (α2-3) linkage, which displayed high sensitivity and high specificity, i.e. 90% and 85% for DSA and 90.91% and 95% for MAA. The new assay has a detection limit of 5 µg µl-1 and enables the quick (30 min) and sensitive detection of severe Dengue cases. The reported point-of-care immunoassay exhibits considerable promise for early identification of patients with Dengue severity.
- 15 September 2022
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 43 (6) , 579-604
Recent advances of lateral flow immunoassay components as “point of need”
Lateral flow immunoassay is the leading Point of Care test and is becoming increasingly essential for its versatile properties. The attraction of lateral flow assay (LFA) has reached its prime position during recent SARS-CoV-2 pandemic and Ebola, Zika epidemics in third world countries where primary screening of the disease and financial issues are very important. During the last decade traditional methodology of LFA was limited to visual detection and qualitative assessment only. However, recently researchers are focusing on the development and improvement of this tool to enhance its specificity, assessment power (quantitative) to make it an alternative to traditional lab-based technology. Modifying working principle and instrumentation, combination of different modern molecular techniques such as Reverse transcription loop mediated isothermal amplification (RT-LAMP), Clustered regularly inter-spaced short palindromic repeat (CRISPR-Cas), Recombinase amplification polymerase (RPA), also association of image-based software, involvement of nanotechnology, implementation of LFA ruler have established authenticity and ultra-specific detection level. These leading immunochromatographic techniques offer simultaneous detection of different analytes from a single sample unit into one multiplex strip and provide the necessary information. This review is a foremost attempt to encompass recent advances of lateral flow assays in combination with molecular biology techniques along with improvements of assay components for improved diagnostic sensitivity and specificity. Some infectious disease diagnosis by LFA with its reporter and low detection limit have also been mentioned in this review.
- 15 September 2022
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 43 (6) , 579-604
Recent advances of lateral flow immunoassay components as “point of need”
Lateral flow immunoassay is the leading Point of Care test and is becoming increasingly essential for its versatile properties. The attraction of lateral flow assay (LFA) has reached its prime position during recent SARS-CoV-2 pandemic and Ebola, Zika epidemics in third world countries where primary screening of the disease and financial issues are very important. During the last decade traditional methodology of LFA was limited to visual detection and qualitative assessment only. However, recently researchers are focusing on the development and improvement of this tool to enhance its specificity, assessment power (quantitative) to make it an alternative to traditional lab-based technology. Modifying working principle and instrumentation, combination of different modern molecular techniques such as Reverse transcription loop mediated isothermal amplification (RT-LAMP), Clustered regularly inter-spaced short palindromic repeat (CRISPR-Cas), Recombinase amplification polymerase (RPA), also association of image-based software, involvement of nanotechnology, implementation of LFA ruler have established authenticity and ultra-specific detection level. These leading immunochromatographic techniques offer simultaneous detection of different analytes from a single sample unit into one multiplex strip and provide the necessary information. This review is a foremost attempt to encompass recent advances of lateral flow assays in combination with molecular biology techniques along with improvements of assay components for improved diagnostic sensitivity and specificity. Some infectious disease diagnosis by LFA with its reporter and low detection limit have also been mentioned in this review.
- 3 November 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (2) , 540-548
Comprehensive investigation of fever cases enrolled during 2019 dengue outbreaks from three hyperendemic regions of North 24 Parganas district of West Bengal, India
For the past several decades, dengue fever has been emerging in epidemic proportions in several regions of the world. During August–September 2019, an increasing number of fever cases were being reported from some areas of North 24 Parganas district of West Bengal, India. Accordingly, outbreak investigation of fever cases from these affected areas of Bongoan, Barasat, and Habra was carried out. To characterize clinical and biochemical features of fever cases as well as to investigate the utility of CRP as a Dengue severity marker in resource‐limited settings. We systematically enrolled 108 patients from the affected region of North 24 Parganas. Standard diagnostic assays along with routine serological and biochemical parameters were performed. Of the 108 patients, 77 (71%) were confirmed with Dengue infection followed by 22 (20%) DENV seronegative and 9 (8%) coinfected DENV cases. Among the 77 confirmed Dengue patients, 53 (69%) had primary infection while 24 (31%) had secondary infection. Among the DENV clinical symptoms, fever (r = 0.50; p = 0.004), headache (r = 0.40; p = 0.03) and abdominal pain (r = −0.40; p = 0.02) were found to bear significant correlation with DENV viral load. The predominant circulating serotype was found to be DENV2. CRP Dengue severity cut‐off level of 10.15 mg/L (AUC: 0.85; 86% sensitivity, 77% specificity) was obtained. CRP had correlation with viral load (r = 0.4, p = 0.05) within febrile phase of infection. The performance of biomarkers can be influenced by local epidemiology, geography, and several patient factors, therefore, CRP Dengue severity cut‐off value may be region‐specific. This study for the first time attempts to estimate CRP Dengue severity cut‐off value based on routine immunoturbidometric evaluation from Dengue Hyperendemic zones of North 24 Parganas, West Bengal, Eastern India.
- 3 November 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (2) , 540-548
Comprehensive investigation of fever cases enrolled during 2019 dengue outbreaks from three hyperendemic regions of North 24 Parganas district of West Bengal, India
For the past several decades, dengue fever has been emerging in epidemic proportions in several regions of the world. During August–September 2019, an increasing number of fever cases were being reported from some areas of North 24 Parganas district of West Bengal, India. Accordingly, outbreak investigation of fever cases from these affected areas of Bongoan, Barasat, and Habra was carried out. To characterize clinical and biochemical features of fever cases as well as to investigate the utility of CRP as a Dengue severity marker in resource‐limited settings. We systematically enrolled 108 patients from the affected region of North 24 Parganas. Standard diagnostic assays along with routine serological and biochemical parameters were performed. Of the 108 patients, 77 (71%) were confirmed with Dengue infection followed by 22 (20%) DENV seronegative and 9 (8%) coinfected DENV cases. Among the 77 confirmed Dengue patients, 53 (69%) had primary infection while 24 (31%) had secondary infection. Among the DENV clinical symptoms, fever (r = 0.50; p = 0.004), headache (r = 0.40; p = 0.03) and abdominal pain (r = −0.40; p = 0.02) were found to bear significant correlation with DENV viral load. The predominant circulating serotype was found to be DENV2. CRP Dengue severity cut‐off level of 10.15 mg/L (AUC: 0.85; 86% sensitivity, 77% specificity) was obtained. CRP had correlation with viral load (r = 0.4, p = 0.05) within febrile phase of infection. The performance of biomarkers can be influenced by local epidemiology, geography, and several patient factors, therefore, CRP Dengue severity cut‐off value may be region‐specific. This study for the first time attempts to estimate CRP Dengue severity cut‐off value based on routine immunoturbidometric evaluation from Dengue Hyperendemic zones of North 24 Parganas, West Bengal, Eastern India.
- Open Access
- 12 January 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Increased levels of pentraxins protein and cytokines bear good association in patients with severe dengue infection
Dengue is an arboviral infection with high rates of morbidity and mortality throughout the tropics and sub-tropics. This work studied the status of pentraxin (CRP/SAP) protein, ferritin, TNF-α and IL-1β levels in Dengue patients of different pathophysiological manifestations. Accordingly, clinically confirmed Dengue cases (n = 97) were enrolled and subsequently blood parameters were studied by Haematology cell counter and Biochemistry Autoanalyser. CRP, SAP, ferritin, TNF-α and IL-1β ELISA were done in all the samples by using standard ELISA kits. Statistical Analysis was done in all the experiments. The levels of CRP (p < 0.0001), SAP (p < 0.0001), ferritin (p < 0.0001), TNF-α (p < 0.0001) and IL-1β (p < 0.0001) were high in patients with Severe Dengue as compared to Dengue without warning signs. High levels of SGOT, SGPT and decreased platelet counts were found in severe patients as compared to Healthy donor. CRP/SAP as well as TNF-α/IL-1β were independently associated with both dengue severity and overall disease manifestation. Statistically significant increased CRP, SAP, ferritin, TNF-α and IL-1β titres were correlated in patients with severe clinical manifestations as compared to mild disease forms of dengue. Elevated levels of pentraxin, TNF-α/IL-1β in blood during dengue infection could act as an early predictor in Severe Dengue infection.
- 12 January 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Open AccessIncreased levels of pentraxins protein and cytokines bear good association in patients with severe dengue infection
Dengue is an arboviral infection with high rates of morbidity and mortality throughout the tropics and sub-tropics. This work studied the status of pentraxin (CRP/SAP) protein, ferritin, TNF-α and IL-1β levels in Dengue patients of different pathophysiological manifestations. Accordingly, clinically confirmed Dengue cases (n = 97) were enrolled and subsequently blood parameters were studied by Haematology cell counter and Biochemistry Autoanalyser. CRP, SAP, ferritin, TNF-α and IL-1β ELISA were done in all the samples by using standard ELISA kits. Statistical Analysis was done in all the experiments. The levels of CRP (p < 0.0001), SAP (p < 0.0001), ferritin (p < 0.0001), TNF-α (p < 0.0001) and IL-1β (p < 0.0001) were high in patients with Severe Dengue as compared to Dengue without warning signs. High levels of SGOT, SGPT and decreased platelet counts were found in severe patients as compared to Healthy donor. CRP/SAP as well as TNF-α/IL-1β were independently associated with both dengue severity and overall disease manifestation. Statistically significant increased CRP, SAP, ferritin, TNF-α and IL-1β titres were correlated in patients with severe clinical manifestations as compared to mild disease forms of dengue. Elevated levels of pentraxin, TNF-α/IL-1β in blood during dengue infection could act as an early predictor in Severe Dengue infection.
- Open Access
- 27 May 2020
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 10, 251
Clinical Proteomics Profiling for Biomarker Identification Among Patients Suffering With Indian Post Kala Azar Dermal Leishmaniasis
Background: Post Kala Azar Dermal Leishmaniasis (PKDL) is a non-fatal dermal sequel of Visceral Leishmaniasis (VL), affecting individuals worldwide. Available diagnostic tools lack sensitivity and specificity toward identifying macular (MAC) PKDL patients, due to low parasite load in patients' sample. Confirmatory test like punch biopsy are invasive and painful. Considering the rural nature of this disease and the prevailing situation of diagnostic scenario, PKDL patients mostly remains unattended from receiving proper medical care. They in turn act as “mobile parasite reservoir,” responsible for VL transmission among healthy individuals (HI). This study aims to identify PKDL disease specific glycated protein biomarkers, utilizing the powerful LC-MS/MS technology, which is the tool of choice to efficiently identify and quantify disease specific protein biomarkers. These identified PKDL disease specific novel glycoproteins could be developed in future as immunochromatographic based assay for efficient case detection. Methodology: Previously our lab had identified importance of glycated (Circulating Immune Complexes) CICs, among PKDL patients. This study aims to further characterize disease specific glycated protein biomarkers, among MAC PKDL patients for both diagnostic and prognostic evaluation of the disease. LC-MS/MS based comparative spectral count analysis of MAC PKDL to polymorphic (POLY) PKDL, HI, and Cured (CR) individuals were performed. Proteins level alterations among all study groups were confirmed by Western blot and enzyme-linked immunosorbant Assay (ELISA). Results: Among MAC PKDL patients 43, 60, 90 proteins were altered compared to POLY PKDL, HI, and CR groups, respectively. Filtering for the most significant proteins, Plasminogen (PLG) and Vitronectin (VTN) were identified which promisingly identified MAC PKDL cases. Active surveillance results from endemic districts of West Bengal revealed drastic rise of MAC PKDL cases, alarming the urgency for field adaptive efficient biomarker. Conclusion: This current study aims to establish PLG and VTN as novel diagnostic and prognostic protein biomarker for MAC and POLY PKDL cases management.
- 27 May 2020
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 10, 251
Open AccessClinical Proteomics Profiling for Biomarker Identification Among Patients Suffering With Indian Post Kala Azar Dermal Leishmaniasis
Background: Post Kala Azar Dermal Leishmaniasis (PKDL) is a non-fatal dermal sequel of Visceral Leishmaniasis (VL), affecting individuals worldwide. Available diagnostic tools lack sensitivity and specificity toward identifying macular (MAC) PKDL patients, due to low parasite load in patients' sample. Confirmatory test like punch biopsy are invasive and painful. Considering the rural nature of this disease and the prevailing situation of diagnostic scenario, PKDL patients mostly remains unattended from receiving proper medical care. They in turn act as “mobile parasite reservoir,” responsible for VL transmission among healthy individuals (HI). This study aims to identify PKDL disease specific glycated protein biomarkers, utilizing the powerful LC-MS/MS technology, which is the tool of choice to efficiently identify and quantify disease specific protein biomarkers. These identified PKDL disease specific novel glycoproteins could be developed in future as immunochromatographic based assay for efficient case detection. Methodology: Previously our lab had identified importance of glycated (Circulating Immune Complexes) CICs, among PKDL patients. This study aims to further characterize disease specific glycated protein biomarkers, among MAC PKDL patients for both diagnostic and prognostic evaluation of the disease. LC-MS/MS based comparative spectral count analysis of MAC PKDL to polymorphic (POLY) PKDL, HI, and Cured (CR) individuals were performed. Proteins level alterations among all study groups were confirmed by Western blot and enzyme-linked immunosorbant Assay (ELISA). Results: Among MAC PKDL patients 43, 60, 90 proteins were altered compared to POLY PKDL, HI, and CR groups, respectively. Filtering for the most significant proteins, Plasminogen (PLG) and Vitronectin (VTN) were identified which promisingly identified MAC PKDL cases. Active surveillance results from endemic districts of West Bengal revealed drastic rise of MAC PKDL cases, alarming the urgency for field adaptive efficient biomarker. Conclusion: This current study aims to establish PLG and VTN as novel diagnostic and prognostic protein biomarker for MAC and POLY PKDL cases management.